Form 483

Kawasumi Laboratories (Thailand) Co., Ltd. Form 483, 2024-05-09

FDA issued a Form 483 to Kawasumi Laboratories (Thailand) Co., Ltd. on 2024-05-09 with 3 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health3 observations

Kawasumi Laboratories (Thailand) Co., Ltd. · Khlong Luang, Thailand · Issued May 9, 2024

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 May 2024
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Thai T Duong

9 May 2024
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Thai T Duong

9 May 2024
21 CFR 820.50

Purchasing controls, Lack of or inadequate procedures

Cited by Thai T Duong

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere